ArticleClinical transplantation2026
Expanding Remote Patient Monitoring for Pre-Lung Transplant Candidates With Interstitial Lung Disease.
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Expanding Remote Patient Monitoring for Pre-Lung Transplant Candidates With Interstitial Lung Disease.Clinical transplantation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionInterstitial lung disease (ILD) is a primary indication for lung transplantation (LTx). Close monitoring of disease progression informs transplant urgency, timing, medical and pre-habilitation management, and remote home monitoring may support frequent assessment of clinical status and response to interventions.
methodsLTx candidates with ILD received a home spirometer, pulse oximeter, and activity tracker. Participants manually entered data weekly and completed the King's Brief ILD questionnaire (KBILD) monthly within a patient portal linked to the electronic medical record (EMR).
resultsOf 63 people approached at the start of outpatient pre-habilitation, 50 (79%) enrolled for additional remote monitoring and 40 (80%) entered data for ≥4 weeks. Reporting adherence was higher for pulse oximetry (82%) and spirometry (69%) than daily steps tracking (31%). During a median LTx waiting period of 11 [4-18] weeks, there were no changes in home spirometry or self-reported health status; however, daily step count decreased (mean 5639 ± 3989-4653 ± 3303; p = 0.04, n = 25). Wait list status for transplant urgency was increased during the study period in 40% of participants. Fraction of inspired oxygen (FiO
conclusionRemote monitoring in LTx candidates with ILD was feasible, with data integrated into the EMR for clinicians to view. This can provide multimodal data to inform clinical status changes and interventions. Future plans include direct device (Wi-Fi, Bluetooth) integration of monitoring tools into the EMR to increase reporting and decrease manual entry errors, and building escalation alerts for changes in spirometry, oximetry, and activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.